Literature DB >> 1876516

Open heart surgery in children of Jehovah's Witnesses: extreme hemodilution on cardiopulmonary bypass.

J I Stein1, H Gombotz, B Rigler, H Metzler, C Suppan, A Beitzke.   

Abstract

Between January 1979 and July 1989, 15 children of Jehovah's Witnesses underwent corrective open surgery for congenital heart disease (CHD) on cardiopulmonary bypass (CPB). Ages ranged from 1.5-17 years and body weight from 9.1-63 kg, with five patients weighing less than 15 kg. Eight children were cyanotic, and two of them had had previous thoracic operations. All operations were performed in moderate to deep hypothermia using a modified version of isovolemic hemodilution with bloodless priming technique of extracorporeal circulation. Mean hematocrit levels decreased from 47.3% (36.9-70%) to 34.6% (27.2-49.1%) after hemodilution, and then to 17.9% (10.5-25.6%) during bypass. They increased again to 34.1% (24.4-50%) at the end of the operation and to 33.4% (25.1-40%) on day 12. All intra- and postoperative hematocrit levels were significantly lower (p less than 0.001). There was one postoperative death, not related to the technique. Our results demonstrate that bloodless cardiac surgery on bypass is feasible in children as shown in this special group of children of Jehovah's Witnesses. Knowing the risks of homologous blood transfusion this technique should be used more extensively in the future.

Entities:  

Mesh:

Year:  1991        PMID: 1876516     DOI: 10.1007/BF02238525

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  VISCOSITY OF NORMAL HUMAN BLOOD UNDER NORMOTHERMIC AND HYPOTHERMIC CONDITIONS.

Authors:  P W RAND; E LACOMBE; H E HUNT; W H AUSTIN
Journal:  J Appl Physiol       Date:  1964-01       Impact factor: 3.531

2.  Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion.

Authors:  D A Ott; D A Cooley
Journal:  JAMA       Date:  1977-09-19       Impact factor: 56.272

3.  Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.

Authors:  D Royston; B P Bidstrup; K M Taylor; R N Sapsford
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

4.  [10 years' experience with heart surgery in Jehovah's witnesses].

Authors:  H Gombotz; B Rigler; C Matzer; H Metzler; G Winkler; K H Tscheliessnigg
Journal:  Anaesthesist       Date:  1989-08       Impact factor: 1.041

5.  [Combination autotransfusion in heart surgery. Use of acute normovolemic hemodilution in coronary heart disease].

Authors:  B von Bormann; J Boldt; D Kling; B Weidler; H H Scheld; G Hempelmann
Journal:  Dtsch Med Wochenschr       Date:  1987-12-04       Impact factor: 0.628

6.  Compensatory mechanisms for acute dilutional anemia.

Authors:  K Messmer
Journal:  Bibl Haematol       Date:  1981

7.  Oxygen transport to tissue under normovolemic moderate and extreme hemodilution during coronary bypass operation.

Authors:  J Niinikoski; V Laaksonen; O Meretoja; J Jalonen; M V Inberg
Journal:  Ann Thorac Surg       Date:  1981-02       Impact factor: 4.330

8.  Continuous arteriovenous haemofiltration in children with postoperative cardiac failure.

Authors:  G Zobel; A Beitzke; J I Stein; M Trop
Journal:  Br Heart J       Date:  1987-11

9.  [Problems in the refusal of blood transfusion].

Authors:  R Riegler
Journal:  Anaesthesist       Date:  1985-02       Impact factor: 1.041

10.  Cardiac operation for congenital heart disease in children of Jehovah's Witnesses.

Authors:  C E Henling; M J Carmichael; A S Keats; D A Cooley
Journal:  J Thorac Cardiovasc Surg       Date:  1985-06       Impact factor: 5.209

View more
  10 in total

1.  Considerations in the surgical treatment of congenital heart disease in children of Jehovah's Witnesses.

Authors:  D A Cooley; C M Burnett
Journal:  Tex Heart Inst J       Date:  1992

2.  Perfusion techniques toward bloodless pediatric open heart surgery.

Authors:  Vincent F Olshove; Thomas Preston; Daniel Gomez; Alistair Phillips; Mark Galantowicz
Journal:  J Extra Corpor Technol       Date:  2010-06

3.  Influence of severe hemodilution on brain function and brain oxidative metabolism in the cat.

Authors:  R Bauer; T Iijima; K A Hossmann
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

4.  [Open heart surgery without blood transfusion for cyanotic congenital cardiac defects].

Authors:  T Sakamoto; Y Nagase; H Watanabe; M Shibairi; K Utsumi; H Nakano; N Kosai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-02

5.  Cardiorespiratory effects of hemic versus nonhemic prime during and immediately following mitral valve replacement in dogs.

Authors:  P Pibarot; T Lanthier; L G Durand; Y Langlois; B Lussier; P Coppens
Journal:  Can J Vet Res       Date:  1995-07       Impact factor: 1.310

6.  Effect of hemodilution on the adequacy of cerebral perfusion under hypothermic cardiopulmonary bypass.

Authors:  H Kawata; S Ohtake; Y Sawa; T Ohata; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-10

7.  Open-heart surgery without homologous blood transfusion in infants and children under simple deep hypothermia.

Authors:  Kazutoshi Okada; Midori Ishida; Hiroshi Okada; Hiroto Nakayama; Jun Aizawa
Journal:  J Anesth       Date:  1998-09       Impact factor: 2.078

8.  Transfusion-free cardiopulmonary bypass in Jehovah's Witness patients weighing less than 5 kg.

Authors:  Wolfgang Boettcher; Frank Merkle; Michael Huebler; Andreas Koster; Fritz Schulz; Michael Kopitz; Hermann Kuppe; Peter Lange; Roland Hetzer
Journal:  J Extra Corpor Technol       Date:  2005-09

9.  [A total correction for tetralogy of Fallot without the use of homologous blood].

Authors:  K Kurisu; K Yonenaga; K Miyamoto; N Furusho; K Nishimura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-06

10.  Attempting to Honor Beliefs of Jehovah's Witnesses at the Edge of Viability in an Infant Born at 23 Weeks' Gestational Age.

Authors:  Charles W Sauer; Krishelle L Marc-Aurele
Journal:  Am J Case Rep       Date:  2016-06-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.